KR100900810B1 - Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder - Google Patents

Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder Download PDF

Info

Publication number
KR100900810B1
KR100900810B1 KR1020070041523A KR20070041523A KR100900810B1 KR 100900810 B1 KR100900810 B1 KR 100900810B1 KR 1020070041523 A KR1020070041523 A KR 1020070041523A KR 20070041523 A KR20070041523 A KR 20070041523A KR 100900810 B1 KR100900810 B1 KR 100900810B1
Authority
KR
South Korea
Prior art keywords
dermis
powder
enzyme
increased
weight
Prior art date
Application number
KR1020070041523A
Other languages
Korean (ko)
Other versions
KR20080096273A (en
Inventor
이명희
윤성란
허담
Original Assignee
허담
동우당제약(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 허담, 동우당제약(주) filed Critical 허담
Priority to KR1020070041523A priority Critical patent/KR100900810B1/en
Publication of KR20080096273A publication Critical patent/KR20080096273A/en
Application granted granted Critical
Publication of KR100900810B1 publication Critical patent/KR100900810B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/03Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
    • A23L19/07Fruit waste products, e.g. from citrus peel or seeds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10Natural spices, flavouring agents or condiments; Extracts thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/40Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
    • A23L3/44Freeze-drying
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof

Abstract

본 발명은 진피의 무배당체 화합물의 함량이 증가된 진피 분말 및 그 제조방법과 분말이 포함된 조성물에 관한 것으로서,The present invention relates to a dermis powder having an increased amount of a non-dodecyl compound of dermis, a method for producing the dermis powder, and a composition containing the powder,

더 자세히는 일반적인 배당체 화합물로 이루어진 감귤 진피에 셀롤라아제, 베타글루카타제, 자일란라제 등으로 이루어진 당 분해 효소처리하여 일정시간을 통해 반응시킴으로써 진피의 용출수율 등의 품질 특성이 향상되면서 헤스페레틴, 나린제닌 등의 무배당체 화합물의 생성 및 함량이 증가되어 무배당체 화합물의 함량이 높은 진피를 제조하는 방법을 특징으로 하는 진피의 무배당체 화합물의 함량이 증가된 진피 분말 및 그 제조방법과 분말이 포함된 조성물에 관한 것이다.More specifically, a citrus dermis consisting of a common glycoside compound is treated with a saccharolytic enzyme such as cellulase, betaglucarase, xylanase, etc., and reacted over a certain period of time to improve quality characteristics such as the elution yield of dermis, , Naringenin, and the like are increased and the content of the non-dodecyl compound is increased to produce a dermis having a high content of the non-dodecyl compound. The dermis powder, ≪ / RTI >

진피 dermis

Description

진피의 무배당체 화합물의 함량이 증가되는 진피 분말 및 그 제조방법과 분말이 포함된 조성물{Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder}BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a dermis powder, a dermis composition containing a dermis compound,

도 1은 본 발명의 따른 플라보노이드 용출추출, 총 페놀성 화합물 함량, 전자공여능, 아질산염 소거능의 변화 추이를 보여주는 contour map       FIG. 1 is a graph showing changes in content of total phenolic compounds, electron donating ability, and nitrite scavenging ability of a flavonoid elution extract, a contour map

도 2는 본 발명의 따른 나린진, 헤스페리딘, 나린제닌, 헤스페레틴의 변화 추이를 보여주는 contour mapFIG. 2 is a graph showing the change of contour map of naringin, hesperidin, naringenin and hesperetin according to the present invention

도 3은 본 발명의 따른 플라보노이드 용출 수율과 나린제닌, 헤스페레틴의 함량을 겹쳐 보여주는 contour mapFIG. 3 is a graph showing the relationship between the yield of flavonoid elution and the content of naringenin and hesperetin according to the present invention.

도 4는 일반 진피와 본 발명의 따른 진피의 플라보노이드 용출 수율을 비교한 결과를 보여주는 그래프4 is a graph showing the results of comparing the yield of flavonoids eluted from the general dermis and the dermis according to the present invention

도 5는 일반 진피와 본 발명의 따른 진피의 전자공여능을 비교한 결과를 보여주는 그래프는 그래프FIG. 5 is a graph showing the results of comparing the electron donating ability of the general dermis and the dermis according to the present invention,

도 6은 일반 진피와 본 발명의 따른 진피의 아질산염 소거능을 비교한 결과를 보여주는 그래프6 is a graph showing the results of comparing nitrite scavenging ability of general dermis and dermis according to the present invention

도 7은 일반 진피와 본 발명의 따른 진피의 ACE 저해활성을 비교한 결과를 보여주는 그래프7 is a graph showing the results of comparing ACE inhibitory activities of general dermis and dermis according to the present invention

도 8은 일반 진피와 본 발명의 따른 진피의 기계 적색도를 비교한 결과를 보여주는 그래프8 is a graph showing the results of comparing the mechanical redness of a general dermis and the dermis according to the present invention

도 9는 본 발명의 바람직한 제조공정도Figure 9 shows a preferred process step of the present invention

본 발명은 진피의 무배당체 화합물의 함량이 증가되는 진피 분말 및 그 제조방법과 분말이 포함된 조성물에 관한 것으로서, The present invention relates to a dermis powder in which the content of a non-dodecyl compound of the dermis is increased, a method for producing the dermis powder, and a composition containing the powder,

진피는 예부터 한약재로 사용되어 왔으며 익은 귤의 껍질을 건조시킨 것. 진피의 약리작용으로는 지방소화효소의 활성증가, 항 알레르기효과, 자궁근육 수축억제, 진정효과, 모세혈관 투과성 억제와 모세혈관 강화에 의한 동맥경화 및 고혈압 예방효과 등이 있는 것으로 알려져 있다. 한방에서는 진피는 위액 분비를 항진하여 소화를 돕는다고 하며, 기관지염 등으로 인한 기침과 가래 증세를 치료하는데 사용되고 있으며, 우리나라에서는 민간요법으로 감기에 걸렸을 때 진피를 끓여 마시기도 하였을 만큼 그 쓰임새가 다양하다. 진피의 주된 생리활성 성분은 나린진과 헤스페리딘 등의 배당체 화합물로 구성되어 있으며, 배당체 형태인 나린진과 헤스페리딘은 무배당체 화합물인 나린제닌과 헤스페레틴에 비해 항산화, 소염, 항암 활성 등이 떨어지는 것으로 알려져 있다(차재영, 조영수 2001. 감귤류 플라보노이드의 생리기능 활성.J Korean Soc Agric Chem Biotechnol 44(2) 122-128). 이러한 배당체 화합물은 인체내에서 소화 흡수도 잘 되지 않는 것으로 알려져 있다. The dermis has been used as herbal medicine since ancient times and dried the skin of ripe orange. The pharmacological actions of the dermis are known to be increased activity of lipid digestive enzymes, antiallergic effect, suppression of uterine muscle contraction, sedative effect, inhibition of capillary permeability, arteriosclerosis by arteriosclerosis, and prevention of hypertension. In one room, the dermis promotes gastric secretion and helps digestion. It is used to cure cough and phlegm symptoms caused by bronchitis, etc. In Korea, it has been used for a long time because it has been boiled and dipped in dandruff when it was caught by cold. . The main physiologically active ingredient of the dermis is composed of glycoside compounds such as naringin and hesperidin. Naringin and hesperidin, which are glycoside forms, are known to have less antioxidative, anti-inflammatory and anti-cancer activities than naringenin and hessperin (chajaeyoung, physiology activity of Cho, Young - Su 2001 citrus flavonoids. Korean J Soc Agric Chem Biotechnol 44 (2) 122-128). These glycoside compounds are known to be poorly digested and absorbed in the human body.

또한 진피는 대부분 약용으로 사용되어지고 있으며, 티백의 형태로 우려먹는 형태로 사용되어지고 있다. 티백의 형태로 우려먹을 경우 용출수율도 높아야 하며, 용출시 시간이 걸리는 단점이 있다.   In addition, most of the dermis is being used for medicinal purposes, and is being used in the form of tea bags in the form of concern. In case of concern in the form of tea bag, the elution yield should be high, and it takes time to elute.

따라서 용출수율이 높으면서 무배당체 화합물 함량이 증가된 진피 분말을 제조하며 제조된 분말은 음료조성물, 식품첨가제 등에 제공하는데 있다.    Therefore, the present invention provides a dermis powder having an increased dissolution yield and an increased non-parasitic compound content, and a powder prepared thereby to provide beverage compositions, food additives and the like.

또한 이를 활용하여 다른 부형제와 조합하여 세립의 형태의 조성물을 만들고자 하였다.   It was also tried to make a composition in the form of fine granules by using it in combination with other excipients.

이에, 본 발명은 상기와 같은 문제점을 해결하기 위해 창안한 것으로 Accordingly, the present invention has been made to solve the above problems

본 발명의 목적은 배당체형태의 생리활성물질을 지닌 감귤 진피에 효소처리 및 일정반응시간을 통해 플라보노이드 용출수율, 총 페놀성 화합물 함량, 전자공여능, 아질산염 소거능, ACE 저하 활성 등의 진피 자체의 품질이 향상되면서도 항산화, 소염, 항암 활성이 뛰어난 무배당체 화합물의 함량이 증가되고 용출수율이 높은 진피 분말 제조방법을 제공하는데 있다. 제조된 진피는 각종가공품 및 조성물에 혼합되어 음료 조성물, 식품첨가제 등에 적용할 수 있는 감귤진피 분말을 제공하는데 있다.It is an object of the present invention to provide a process for preparing a citrus fruit having a physiologically active substance in the form of a glycoside by the enzymatic treatment and the quality of the dermis itself such as flavonoid elution yield, total phenolic compound content, electron donating ability, nitrite scavenging activity, Which has an increased antioxidant, anti-inflammatory and anticancer activity, and which has a high elution yield. The produced dermis is mixed with various processed products and compositions to provide citrus dandelion powder which can be applied to beverage composition, food additive and the like.

본 발명의 또 다른 목적은 감귤 진피의 세립이 이루어지게 다른 부형제와 조합하여 그대로 섭취할 수 있는 조성물을 제공하는데 있다. Another object of the present invention is to provide a composition which can be taken intact in combination with other excipients so that the flesh of the mandarin dermis is formed.

본 발명의 구성 및 작용을 살펴보면,The structure and operation of the present invention will be described.

본 발명을 통한 진피분말의 제조방법은 도 9에 도시된 바와 같이 감귤을 세척하는 제1단계와, 껍질 분리 및 세절하는 제2단계와, 세절된 껍질에 효소첨가 및 일정한 시간으로 반응하는 제3단계와, 동결 건조하여 분말화되는 제4단계를 통해 진피분말이 구성된다.As shown in FIG. 9, the method for producing dermal powder according to the present invention comprises a first step of washing citrus fruits, a second step of separating and shredding the shells, a step of adding enzyme to the chopped shells, 3, and lyophilization to form a dermis powder in the fourth step.

또한 셀롤라아제, 베타글루카타제, 자일란라제 등으로 이루어진 당 분해 효소처리하여 일정시간을 통해 반응시킴으로써 진피의 품질특성 특히 용출수율이 향상되면서도 무배당체 화합물의 생성 및 그 함량이 증가되어 무배당체 화합물의 함량이 높은 진피를 제조할 수 있도록 구성되며 이는 아래의 실시 예에 의한 실험을 통해 증명하도록 한다.In addition, by treating with a saccharolytic enzyme such as cellulase, betaglucarase, xylanase and the like for a predetermined period of time, the quality of the dermis, especially the elution yield, is increased, and the production and content of the undecanoic compound are increased, Of the dermis of the present invention can be produced, and this will be demonstrated through an experiment according to the following examples.

본 실험은 일반 진피와 본 발명의 실시 예에 따른 진피와의 플라보노이드 추출수율, 총 페놀성 화합물 함량, 전자공여능, 아질산염 소거능, ACE 저해 활성 등의 품질 특성의 비교가 이루어지는 것이다.The present experiment compares the quality characteristics such as flavonoid extraction yield, total phenolic compound content, electron donating ability, nitrite scavenging activity and ACE inhibitory activity of the general dermis and the dermis according to the embodiment of the present invention.

또한 본 실험은 일반 진피와 본 발명의 실시 예에 따른 진피와의 무배당체 화합물인 헤스페레틴과 나린제닌의 함량변화를 통해 플라보노이드의 조성의 비교가 이루어지는 것이다.In addition, this experiment compares the composition of flavonoids by changing contents of hesperetin and naringenin, which are undecodomeric compounds of general dermis and dermis according to the embodiment of the present invention.

상기의 실험결과를 통해 최적의 효소농도 및 반응시간을 규명하도록 한다.The optimal enzyme concentration and reaction time are identified through the above experimental results.

<실시 예><Examples>

2006년 농약, 왁스와 같은 성분이 포함되지 않은 제주산 유기농 감귤을 사용하여 껍질을 일정한 크기로 0.5mm크기로 세절한 후 실험에 사용하였다.  In 2006, Jeju organic citrus fruits, which do not contain pesticides, waxes, etc., were used.

효소처리Enzyme treatment

세절된 껍질과 물의 비율을 1:3으로 혼합하고 전체 부피에 대해 셀룰라아제, 베타글루카타제 및 자일란라제가 주성분인 Viscozyme L(Viscozyme, Novozyme Co. 덴마크)을 일정한 농도로 첨가하여 40℃에서 일정한 시간 반응을 하였다. 즉 고품질의 진피를 제조하고자 표 1과 같이 효소농도 (0, 0.5, 1, 1.5, 2 %) 및 효소처리 시간(0, 6, 12, 18, 24 hr)에 따른 중심합성실험계획으로 효소처리한 후 동결건조(효소처리를 하면 거의 대부분 분해되어서 액화되어지므로 효소처리한것을 모두 동결건조 함)하여 일부 큰 입자를 분말화하여 진피의 품질특성 및 플라노보이드 조성을 살펴보고자 하였다.   A mixture of cellulase, betaglucarase and xylan lase active ingredient Viscozyme L (Viscozyme, Novozyme Co. Denmark) was added to the whole volume at a constant concentration at a ratio of 1: 3, Lt; / RTI &gt; In order to produce high-quality dermis, enzymatic treatment with the enzyme concentration (0, 0.5, 1, 1.5, 2%) and enzyme treatment time (0, 6, 12, 18, 24 hr) And then lyophilized (lyophilized by enzymatic treatment, liquefied and liquefied, so all of the enzymes treated were lyophilized), and some large particles were pulverized to examine the quality characteristics of dermis and the composition of the planovoids.

표 1Table 1

Figure 112007032153926-pat00001
Figure 112007032153926-pat00001

플라보노이드 추출Flavonoid extraction

귤피에서 플라보노이드의 추출은 Perfetti 방법을 참조하여 다음과 같이 하였다. 분말화된 시료 1g을 취하여 20% DMF methanol (n,n-di-methylformamide) 와 methanol을 20 : 80의 부피비로 혼합) 용액 20ml씩을 가하여 4시간 동안 90℃ 수용상에서 환류 추출하였다. The extraction of flavonoids from citrus fruits was carried out as follows with reference to the Perfetti method. 1 g of the powdered sample was mixed with 20% DMF methanol (n, n-di-methylformamide) and methanol in a volume ratio of 20:80) and the mixture was refluxed at 90 ° C for 4 hours.

수율yield

플라보노이드 추출된 추출물을 항량을 구한 수기에 일정량 넣어 105℃에서 상압가열건조하여 그 고형분함량을 측정하였다. The extracts of flavonoids were added to a handful of water, and the solids content was measured by heating at 105 ° C under atmospheric pressure.

플라보노이드 분석Flavonoid analysis

추출액을 냉각한 후 여과하고 20% DMF methanol 용액을 사용하여 25ml로 정용하였다. 이액을 0.45㎛ filter로 여과하여 HPLC 분석용 시료로 하였다. The extract was cooled, filtered and diluted to 25 ml with 20% DMF methanol. This solution was filtered with a 0.45 mu m filter to prepare a sample for HPLC analysis.

플라보노이드 분석Flavonoid analysis

Figure 112007032153926-pat00002
Figure 112007032153926-pat00002

총 페놀성 화합물 함량 측정Determination of total phenolic compound content

각 추출물의 총 페놀성 화합물 함량은 Folin-Denis법(17)에 따라 비색정량하였다. 즉, 추출액을 100배 희석한 검액 5ml Folin-Ciocalteu 시약 5ml를 가하여 혼합하고 3분 후 10% Na2CO3 5ml를 넣어 진탕하고 1시간 실온에서 방치하여 700nm에서 흡광도를 측정하였다. 대조구는 검액 대신 증류수를 넣어 동일하게 처리하였다. 이때 표준물질로는 tannic acid를 5~50㎍/ml의 농도로 조제하여 검량곡선의 작성에 사용하였다. The total phenolic compound content of each extract was colorimetrically determined according to the Folin-Denis method (17). That is, 5 ml of Folin-Ciocalteu reagent was added to 5 ml of the sample solution diluted 100 times with the extract, and after 3 minutes, 5 ml of 10% Na 2 CO 3 was added and the mixture was shaken and left at room temperature for 1 hour to measure the absorbance at 700 nm. The control was treated in the same way with distilled water instead of the test solution. At this time, tannic acid was prepared as a standard substance at a concentration of 5 ~ 50 μg / ml and used to prepare a calibration curve.

전자공여능(EDA)Electron donating ability (EDA)

시험용액의 전자공여능(electron donating ability, EDA) 시험은 α,α-diphenyl-β-picrylhydrazyl(DPPH)를 사용한 방법으로 측정하였다. 즉, DPPH 시약 12mg을 absolute ethanol 100ml에 용해한 후 증류수 100ml를 가하고 50% ethanol 용액을 공시험으로 하여 517nm에서 DPPH용액의 흡광도를 약 1.0으로 조정한 후 이 용액 5ml를 취하여 시료용액 0.5ml와 혼합한 후 상온에서 30초간 방치시킨 다음 517nm에서 흡광도를 측정하여 시료 첨가구와 무첨가구의 흡광도 차이를 백분율(%)로 표시하여 전자공여능으로 하였다. The electron donating ability (EDA) of the test solution was measured by the method using α, α-diphenyl-β-picrylhydrazyl (DPPH). That is, 12 mg of DPPH reagent is dissolved in 100 ml of absolute ethanol, 100 ml of distilled water is added, 50% ethanol solution is blanked, the absorbance of the DPPH solution is adjusted to 1.0 at 517 nm, 5 ml of the solution is mixed with 0.5 ml of the sample solution After incubation at room temperature for 30 seconds, the absorbance at 517 nm was measured, and the difference in absorbance between the sample added and the non-added sample was expressed as a percentage (%) to be the electron donating ability.

Figure 112007032153926-pat00003
Figure 112007032153926-pat00003

아질산염 소거능Nitrite scavenging ability

Kato 등의 방법으로 520nm에서 비색정량하였다. 즉, 1mM NaCO3용액 1㎖에 소정 농도의 시료를 첨가하고 여기에 0.1N HCl(pH 1.2)과 0.2M 구연산 완충액(pH3.0, 4.2 및 6.0)을 사용하여 반응용액의 pH를 각각 1.2, 3.0, 4.2 및 6.0으로 조정하여 각 반응용액을 10㎖로 정용하였다. 각 반응용액은 37℃에서 1시간 동안 반응시킨 후 1㎖를 취해 2% 초산 용액 5㎖를 첨가한 다음, Griess 시약(30% acetic acid로 각각 조제한 1% sulfanilic acid와 1% naphthylamine을 1:1비로 혼합한 것, 사용직전 조제) 0.4㎖를 가하여 잘 혼합시켜 실온에서 15분간 방치시킨 후 분광광도계(Shimadzu UV-1601PC, Japan)를 사용하여 520nm에서 흡광도를 측정하여 아래식에 의하여 아질산염 소거율을 구하였다. Colorimetric determination was made at 520 nm by Kato et al. That is, a sample of a predetermined concentration was added to 1 ml of a 1 mM NaCO 3 solution, and the pH of the reaction solution was adjusted to 1.2, 0.1, and 1, respectively, using 0.1 N HCl (pH 1.2) and 0.2 M citric acid buffer (pH 3.0, 3.0, 4.2 and 6.0, and each reaction solution was adjusted to 10 ml. Each reaction solution was incubated at 37 ° C for 1 hour, and then 1 ml of 2% acetic acid solution (5 ml) was added, and 1% sulfanilic acid and 1% naphthylamine (1: (Shimadzu UV-1601PC, Japan) was used to measure the absorbance at 520 nm, and the nitrite scavenging rate was measured according to the following equation. The absorbance was measured using a spectrophotometer (Shimadzu UV-1601PC, Japan) Respectively.

Figure 112007032153926-pat00004
Figure 112007032153926-pat00004

N : 아질산염 소거율    N: nitrite scavenging rate

A : 1mM NaNO2 용액에 시료를 첨가하여 1시간 방치시킨 후의 흡광도A: Absorbance after left standing for 1 hour by adding sample to 1 mM NaNO 2 solution

B : NaNO2 용액의 흡광도B: Absorbance of NaNO 2 solution

C : 시료자체의 흡광도    C: Absorbance of the sample itself

ACE 저해 활성ACE inhibitory activity

Angiotensin converting enzyme 저해효과 측정은 Cushman과 Ondetti의 방법을 변형하여 행하였다. 즉, 반응구는 0.3M NaCl을 함유하는 0.1M potassium phosphate buffer(pH 8.3)에 기질인 hippuryl-L-histidyl-L-leucine(HHL, Sigma, H1635) 2.5mM을 녹인 액 0.15mL, ACE(Sigma, A6778, 0.2 unit/mL) 0.1mL와 각 추출시료 용액 0.1mL를 혼합하였으며, 대조구는 추출시료 대신 증류수 0.1mL를 첨가하여 37℃에서 30분간 반응시키고, 1N HCl 0.25mL 첨가로 반응을 중지시킨 뒤 ethyl aacetate를 1,5mL 첨가하였다. Ethyl acetate 층으로부터 용매를 증류시킨 잔사에 1mL의 증류수를 가하여 추출된 hippuric acid를 분광광도계를 사용하여 228nm에서 흡광도를 측정한 후 다음 식에 따라 저해율을 구하였다.  Angiotensin converting enzyme inhibitory effect was measured by Cushman and Ondetti method. The reaction solution was prepared by dissolving 2.5 mM of hippuryl-L-histidyl-L-leucine (HHL, Sigma, H1635) in 0.1 M potassium phosphate buffer (pH 8.3) containing 0.3 M NaCl and 0.15 mL of ACE A6778, 0.2 unit / mL) and 0.1 mL of each sample solution were mixed. For the control, 0.1 mL of distilled water was added to the control sample, and the reaction was carried out at 37 ° C. for 30 minutes. The reaction was stopped by addition of 0.25 mL of 1N HCl 1.5 mL of ethyl aacetate was added. Ethyl acetate was distilled from the solvent and 1 mL of distilled water was added to the residue. The absorbance of hippuric acid was measured at 228 nm using a spectrophotometer.

Figure 112007032153926-pat00005
Figure 112007032153926-pat00005

A : 반응구의 hippuric acid 생성량A: The amount of hippuric acid produced in the reaction mixture

B : 대조구의 hippuric acid 생성량B: hippuric acid production in the control

1. 품질특성1. Quality Characteristics

효소처리된 감귤껍질을 동결 건조한 분말에 대한 품질특성으로 표 1에 따른 레벨을 상호 조합하여 수율, 총 페놀성 화합물 함량, 전자공여능, 아질산염 소거능을 측정하여 그 결과를 표 2에 나타내었다. Table 2 shows the yield, total phenolic compound content, electron donating ability, and nitrite scavenging ability of the enzyme-treated citrus peel in combination with the levels shown in Table 1 as quality characteristics for the lyophilized powder.

표 2. Table 2.

Figure 112007032153926-pat00006
Figure 112007032153926-pat00006

표 2에 나타난 바와 같이 용출수율의 경우 일반진피의 경우 48.49%이나 효소처리를 하였을 경우 63.03~72.97%로 용출수율이 높은 것으로 나타났다. 또한 감귤껍질을 일반 건조 하였을 때와 동결 건조한 것을 비교해 보았을 때, 동결 건조한 것은 50.36%로 일반건조보다는 약간 높으나 큰 차이가 없는 것으로 나타났다. 총 페놀성 화합물 함량의 경우 일반진피의 경우 7.87 mg%였으며, 효소처리를 하였을 때 8.24~10.94 mg%로 다소 높으나 일반진피와 큰 차이가 나지는 않았다. 전자공여능의 경우 일반진피의 경우 7.54%였으나, 효소처리 하였을 경우 13.56~18.38%로 일반진피보다 효소처리한 것이 더 높은 활성을 지니는 것으로 나타났다. 아질산염 소거능의 경우 일반진피는 1.50%였으나 효소처리를 하였을 경우 17.79~23.43%로 높은 활성을 지니는 것으로 나타났다. As shown in Table 2, the elution yield was 48.49% for the general dermis and 63.03 ~ 72.97% for the enzyme treatment. In addition, when the citrus peel was compared with the freeze-dried one, the freeze-dried amount was 50.36%, which is slightly higher than the general dryness, but not significantly different. The contents of total phenolic compounds were 7.87 mg% in the general dermis and 8.24 ~ 10.94 mg% in the enzyme treatment, but it was not much different from the general dermis. In the case of electron donating ability, 7.54% in the case of general dermis, but 13.56 ~ 18.38% in case of enzyme treatment, showed that enzyme treatment of the general dermis has higher activity than general dermis. In the case of nitrite scavenging ability, general dermis was 1.50%, but it was 17.79 ~ 23.43% when treated with enzyme.

이러한 결과를 바탕으로 반응표면분석을 위해 2차 회귀식을 구한 결과 표 3과 같으며, 전반적으로 R2 0.9이상으로 5%이내의 유의수준에서 유의성이 인정되는 것으로 나타났다. Based on these results, the second-order regression equation for the response surface analysis is shown in Table 3, and overall significance was recognized at the significance level of R2 0.9 or higher and within 5%.

표 3Table 3

Figure 112007032153926-pat00007
Figure 112007032153926-pat00007

1) X1 : enzyme concentration (%), X2 : time (hr) 1) X1: enzyme concentration (%), X2: time (hr)

상기 표 3의 회귀식을 바탕으로 contour map 및 최적값을 예측한 결과 도 1, 표 4와 같다. Based on the regression equations in Table 3, contour maps and optimal values are predicted as shown in FIGS. 1 and 4. FIG.

표 4. Table 4.

Figure 112007032153926-pat00008
Figure 112007032153926-pat00008

상기 표 4 및 도 1에서 나타난 바와 같이 용출수율의 경우 효소농도 1.41% 및 반응시간 15.38 hr 일 때 최대값을 나타내는 형태의 그래프로 나타났다. 총 페놀성 화합물 함량의 경우 효소첨가 농도가 높고 반응시간이 길수록 높은 함량을 지니는 것으로 나타났으며, 효소처리 농도 1.55% 및 반응시간 22.00 hr일대 최대값으로 예측되어졌다. 전자공여능의 경우 효소처리 농도 1.32% 및 반응시간 16.57 hr 일때 높은 함량을 나타내는 것으로 예측되어졌으며, 그래프도 최대점을 지니는 형태로 나타났다. 아질산염 소거능의 경우 효소처리 농도 1.165% 및 반응시간 17.67 hr에서 최대값을 지니는 것으로 예측되었다. 전반적으로 총 페놀성 화합물 함량, 전자공여 능, 아질산염소거능의 경우 표 5에 나타난 바와 같이 효소농도보다는 효소반응시간에 영향을 받는 것으로 나타났다.As shown in Table 4 and FIG. 1, the elution yield was a graph showing the maximum value when the enzyme concentration was 1.41% and the reaction time was 15.38 hr. The contents of total phenolic compounds showed higher contents of enzyme and higher reaction time, and it was predicted that the enzyme treatment concentration was 1.55% and the reaction time was 22.00 hr. The electron donating ability was predicted to be high when the enzyme treatment concentration was 1.32% and the reaction time was 16.57 hr, and the graph showed a maximum point. The nitrite scavenging activity was predicted to have the maximum value at the enzyme treatment concentration of 1.165% and the reaction time of 17.67 hr. Overall, the total phenolic compound content, electron donating ability and nitrite scavenging activity were affected by the enzyme reaction time rather than the enzyme concentration as shown in Table 5.

표 5Table 5

Figure 112007032153926-pat00009
Figure 112007032153926-pat00009

***Significant at 1% level, *** Significant at 1% level,

**Significant at 5% level,** Significant at 5% level,

*Significant at 10% level* Significant at 10% level

2. 플라보노이드 조성2. Flavonoid Composition

감귤류에 유해하는 주요 플라보노이느 화합물은 배당체 형태인 나린진과 헤스페리딘 그리고 이들의 무배당체 형태인 나린제닌과 헤스페레틴이며, 그 밖에도 rutin, deosmine, nobiletin, tangeretin 등이 있다. The major flavonoid compounds that are harmful to citrus are the glycoside forms of naringin and hesperidin and their undecomposed forms of naringenin and hesperetin, as well as rutin, deosmine, nobiletin and tangeretin.

감귤류의 플라보노이드 중에서 항산화 활성은 헤스페레틴이 가장 높았으며, aglycone 형태인 헤스페레틴과 나린제닌은 그들의 glycoside 형태인 나린진과 헤스 페리딘 보다 높은 것으로 보고되고 있다. 따라서 본 실시예에서 효소처리를 하였을 때 감귤껍질의 플라보노이드 조성, 즉 나린진, 헤스페리딘, 헤스페레틴, 나린제닌의 변화를 표 1에 따른 레벨을 상호 조합하여 살펴보고자 하였다.Among the citrus flavonoids, the antioxidant activity was highest in the hessperin, and the aglycone forms hessperine and naringenin were reported to be higher than their glycoside forms, naringin and hesperidin. Thus, in this example, the flavonoid composition of the citrus peel when subjected to the enzyme treatment, namely the levels of naringin, hesperidin, hesperetin and naringenin,

표 6Table 6

상기 표 6에서 보는 바와 같이 일반 진피의 경우 헤스페리딘 함량이 58.85 mg/g으로 나타났으며, 그 외 플라보노이드는 검출되지 않았다. 또한 효소를 첨가하지 않고 12 hr 정도 반응하였을때 헤스페리딘은 54.17 mg/g, 나린제닌 0.20 mg/g, 헤스페레틴 0.13 mg/g 및 나린진은 검출되지 않았으며, 동결건조하열경우에는 hesperidin 54.30 mg/g으로 나타났으며, 그 외는 검출되지 않는 것으로 나타났다. 그러나 효소처리함에 따라 헤스페리딘 함량은 감소하였으며 반면에 나린제닌 및 헤 스페레틴 함량은 증가하는 것으로 나타났다. As shown in Table 6, the content of hesperidin was 58.85 mg / g in the general dermis and no other flavonoids were detected. When hesperidin was reacted for about 12 hr without enzyme addition, 54.17 mg / g of hesperidine, 0.20 mg / g of naringenin, 0.13 mg / g of hesperetin and naringin were not detected, and hesperidin 54.30 mg / g, and others were not detected. However, the amount of hesperidin decreased with enzymatic treatment, while that of naringenin and hesperetin increased.

이러한 결과는 바탕으로 SAS 프로그램을 통한 반응표면분석하여 2차 회귀식을 구한결과 표 7과 같이, 헤스페리딘은 R2 0.8693으로 10%이내의 유의수준에서 유의성이 인정되는 것으로 나타났으며, 나린진, 나린제닌 및 헤스페레틴의 경우는 R2 0.9 및 5%이내의 유의수준에서 유의성이 인정되는 것으로 나타났다. Based on these results, the second-order regression equation was obtained from the response surface analysis through SAS program. As shown in Table 7, the significance level of hesperidin to R2 0.8693 was found to be within 10% of the significance level. Naringin, And in case of hesperetin, significance was recognized at significance level within R2 0.9 and 5%.

표 7Table 7

Figure 112007032153926-pat00011
Figure 112007032153926-pat00011

1) X1 : enzyme concentration (%), X2 : time (hr) 1) X1: enzyme concentration (%), X2: time (hr)

상기 표 7의 회귀식을 바탕으로 contour map 및 최적값 예측조건을 구한결과 도 2 및 표 8과 같다. Based on the regression equations in Table 7, the contour map and the optimum value prediction condition are shown in FIG. 2 and Table 8.

표 8Table 8

Figure 112007032153926-pat00012
Figure 112007032153926-pat00012

상기 표 8 및 도 2에서 나타난 바와 같이 나린진의 경우 효소농도 1.20% 및 반응시간 11.88 hr에서 최대값으로 예측되었으며, 헤스페리딘의 경우는 효소처리함에 따라 감소하는 것으로 나타났으며 효소처리 농도 0.32% 및 반응시간 3.25 hr일때 최대값으로 예측되었다. 나린제닌의 경우 효소반응시간이 길어 질수록 그 함량이 증가하는 것으로 나타났으며, 효소처리 농도 1.34% 및 반응시간 23.27 hr 일때 최대값으로 예측되었다. 헤스페레틴의 경우 효소처리 농도가 증가하고 반응시간이 길어질수록 그 함량이 증가하는 것으로 나타났으며, 효소처리 농도 1.69% 및 반응시간 20.74 hr 일때 최대값으로 예측되었다. 효소처리조건의 플라보노이드 성분 영향도를 살펴본 결과 표 9에 나타난 바와 같이 전반적으로 반응시간에 영향을 받는 것으 로 나타났다. As shown in Table 8 and FIG. 2, the maximum value was predicted at the enzyme concentration of 1.20% and the reaction time of 11.88 hr in case of Naringin. In the case of hesperidin, the enzyme concentration decreased by 0.32% The maximum value was predicted at 3.25 hr. In the case of naringinin, the content increased with increasing enzyme reaction time. The maximum value was predicted when enzyme treatment concentration was 1.34% and reaction time was 23.27 hr. In the case of hesperetin, the enzyme concentration increased and the reaction time increased. The maximum value was estimated at the enzyme treatment concentration of 1.69% and the reaction time of 20.74 hr. As a result of examining the influences of flavonoid components on the enzyme treatment conditions, it was found that the overall reaction time was affected as shown in Table 9.

표 9Table 9

Figure 112007032153926-pat00013
Figure 112007032153926-pat00013

***Significant at 1% level,*** Significant at 1% level,

**Significant at 5% level, ** Significant at 5% level,

*Significant at 10% level  * Significant at 10% level

상기 고품질의 진피를 제조하기 위한 최적 효소처리조건을 설정하기 위하여 용출수율과 무배당체 화합물인 헤스페레틴 및 나린제닌의 함량이 우수한 조건을 설정하고자 하였다. 그 결과 각각의 contour map을 겹치기 한 결과 도 3과 같이 나타났으며, 최적의 효소처리 조건을 설정한 결과 표 10에서 나타난 바와 같이 효소처리 농도 1.1~1.8% 및 반응시간 15 ~ 20 hr 으로 나타났다. 따라서 최적의 효소처리 조건으로는 효소처리 농도 1.5% 및 반응시간 18 hr 으로 설정되어졌다.In order to set the optimum conditions for enzyme treatment for producing the high-quality dermis, it was attempted to establish conditions of excellent elution yield and content of non-dividing compounds hesperetin and naringenin. As a result, the result of overlapping each contour map was as shown in Fig. 3. As a result of setting the optimum enzyme treatment conditions, the enzyme treatment concentration was 1.1 ~ 1.8% and the reaction time was 15 ~ 20 hr. Therefore, the optimum conditions for enzyme treatment were set as 1.5% enzyme reaction time and 18 hr reaction time.

표 10Table 10

Figure 112007032153926-pat00014
Figure 112007032153926-pat00014

기존의 일반 진피제조방법으로 40℃에서 건조만 한 진피분말(CC)과 실시 예의 조건으로 설정된 효소처리 농도 1.5% 및 반응시간 18 hr 반응한 후 동결건조 처리한 진피분말(CE)에 대해 각각의 품질 특성을 비교하였다. In the conventional dermis production method, the dermal powder (CC) dried at 40 ° C and the enzyme treatment concentration set at 1.5% and the reaction time set for the reaction time of 18 hr, Quality characteristics were compared.

1) 용출수율 및 Flavonoid 함량1) Elution yield and Flavonoid content

각각의 시료 1g을 95℃ 증류수 100ml에 1hr 용출하여 가용성 고형분 함량을 측정하여 수율로 계산하였다. 그 결과 도 4에 도시된 바와 같이 효소처리한 진피분말이 용출율이 더 높은 것으로 나타났다.1 g of each sample was eluted in 100 ml of distilled water at 95 ° C for 1 hour, and the soluble solid content was measured and calculated as a yield. As a result, as shown in FIG. 4, the enzyme-treated dermis powder showed a higher dissolution rate.

또한 플라보노이드 조성을 비교한 결과 일반진피의 경우 헤스페리딘만 검출이 되었으나, 표 11과 같이 효소처리한 진피분말의 경우 무배당체 화합물인 헤스페레틴 및 나린제닌이 높은 함량으로 나타났다As a result of comparing the composition of flavonoids, only hesperidin was detected in the general dermis, but in the case of the dermis powder treated with the enzyme as shown in Table 11, the non-dividing compounds hesperetin and naringenin were high contents

표 11Table 11

Figure 112007032153926-pat00015
Figure 112007032153926-pat00015

2) 전자공여능, 아질산염 소거능, ACE 저해활성2) Electron donating ability, nitrite scavenging activity, ACE inhibitory activity

일반진피분말과 효소처리한 진피분말의 기능적 특성으로 전자공여능, 아질산염 소거능, ACE저해활성을 조 플라보노이드 추출액을 일정한 농도(10000, 5000, 2500 ppm)로 조절하여 각각의 활성을 비교하였다. The activities of electron donating ability, nitrite scavenging ability and ACE inhibitory activity were controlled by controlling the concentration of crude flavonoid extract at a constant concentration (10000, 5000, 2500 ppm) by the functional properties of general dermis powder and enzyme - treated dermis powder.

전자공여능, 아질산염 소거능 및 ACE 저해활성의 경우 의 경우 도 5, 6, 7과 같이 효소처리한 진피분말(CE)이 일반진피(CC)보다 더 높은 활성을 지는 것으로 나타났으며, 농도가 높을수록 그 활성이 높은 것으로 나타났다. 전반적으로 일반진피(CC)에 비해 효소처리한 진피(CE)가 2배정도 더 높은 것으로 나타났다.   In the case of electron donating ability, nitrite scavenging ability and ACE inhibiting activity, as shown in FIGS. 5, 6 and 7, the enzyme treated dermal powder (CE) showed higher activity than the common dermal CC, The activity was found to be high. Overall, the enzyme-treated dermis (CE) was twice as high as the normal dermis (CC).

3) 기계적 색도3) Mechanical color

일반진피(CC)와 효소처리한 진피(CE)의 기계적색도를 비교한 결과 도 8과 같이 백색도(L value) 및 황색도(b value)의 경우 일반진피가 효소 처리한 진피에 비해 더 높은 값을 나타내었으며, 적색도(a value)의 경우에는 일반진피보다 효소처리한 진피가 더 높은 값으로 나타났다. 이는 효소처리 되어짐에 따라 감귤껍질자체의 갈변 이 다소 일어나 약간의 적색을 띄는 것으로 여겨진다. As a result of comparing the mechanical chromaticity of the general dermis (CC) with that of the enzyme-treated dermis (CE), the whiteness (L value) and the yellow value (b value) And a value of enzyme treated dermis was higher than that of general dermis. It is believed that as the enzyme treatment, the browning of the citrus peel itself occurs somewhat and has a slight red color.

상기의 실시 예에 의거하여 감귤 진피에 셀롤라아제, 베타글루카타제, 자일란라제 등으로 이루어진 당 분해 효소를 첨가하고 일정시간을 통해 반응시킴으로써 수율, 총 페놀성 화합물 함량, 전자공여능, 아질산염 소거능, ACE 저하 활성등의 품질이 향상되었으며 플라보노이드 조성물중 항산화, 소염, 항암 활성이 뛰어난 나린제닌과 헤스페레틴등의 무배당체 화합물이 생성 및 그 함량이 증가되는 것을 알 수 있으며 이들 조건을 조합하여 최적의 효소처리조건은 효소처리농도는 1.1 내지 1.8%이며 반응시간은 15 내지 20시간이며 더 바람직하게는 효소처리농도 1.5%, 반응시간은 18시간으로 이루어지는 것을 알 수 있다.According to the above example, the saccharide bark was reacted with a saccharolase, beta-glucacase, xylanase, or the like, for a predetermined period of time, thereby yielding the total phenolic compound content, electron donating ability, nitrite scavenging ability, ACE degradation activity, and the production and content of non-parasitic compounds such as naringenin and hesperetin, which are excellent in antioxidation, anti-inflammation and anticancer activity among the flavonoid compositions, are increased. The enzymatic treatment conditions are that the enzyme treatment concentration is 1.1 to 1.8%, the reaction time is 15 to 20 hours, more preferably the enzyme treatment concentration is 1.5%, and the reaction time is 18 hours.

상기의 실험을 통해 최적의 조건으로 효소처리되는 진피분말은 식품이나 식품첨가제에 유효성분으로 제조될 수 있으며 이는 식품의 특별한 제한없이 사용 목적에 따라 유효성분으로 제조될 수 있다.The dermis powder treated with the enzyme under the optimum conditions can be prepared as an active ingredient in foods or food additives, and can be prepared as an active ingredient according to the purpose of use without any specific restriction on the food.

예를 들어 진피분말 49.10%, 유당 16.37%, 전분 16.37%, 포도당 16.37%, 만닛톨 1.63%, 비타민 C 0.08%, 사과산 0.08%를 첨가한 조성물을 혼합구성하고, 상기 조성물에 소량의 물을 첨가하여 혼합하여 18mesh 체로 걸러낸 후 50℃에서 2시간정도 건조한 진피분말 조성액을 구성하여 분말 형태로 섭취하거나 물에 태워 차의 형태로 섭취할 수 있도록 구성하는 것이다.For example, a composition comprising 49.10% of dandruff powder, 16.37% of lactose, 16.37% of starch, 16.37% of glucose, 1.63% of mannitol, 0.08% of vitamin C and 0.08% of malic acid was mixed and a small amount of water The mixture is then filtered through an 18 mesh sieve and dried at 50 ° C for about 2 hours to form a powdery dermal composition which can be taken in powder form or in water to be ingested in the form of tea.

이상에서 상세히 설명한 바와 같이 본 발명에 의해 최적의 효소처리농도 및 반응시간을 규명하여 진피에 적용 구성함으로써 일반 진피에 대비하여 품질이 향상되며 특히 용출수율이 높고, 무배당체 화합물의 함량이 증가되는 진피 분말을 구성하여 상기 진피 분말이 유효성분으로 구성되는 음료 조성물과 식품첨가제를 제공함으로써 소비자의 건강증진에 도움이 되는 그 효과가 다대한 발명이라 하겠다.      As described above, according to the present invention, by optimizing enzyme concentration and reaction time, it can be applied to the dermis to improve quality in comparison with general dermis. In particular, the dermis, which has a high elution yield and an increased non- Powder is constituted so that the dermis powder is composed of an effective ingredient, and the effect of contributing to the health promotion of a consumer by providing a food additive is a multi-purpose invention.

Claims (3)

감귤을 세척하는 제1단계와, 껍질 분리 및 세절하는 제2단계와, 세절된 껍질과 물의 중량을 1:3으로 혼합하고, 셀롤라아제, 베타글루카나제, 자일란라제가 주성분인 효소처리제를 첨가하여 진피의 효소처리농도는 혼합물의 전체 부피에 1.1 내지 1.8% 이며 반응시간 15 내지 20시간으로 반응하는 제3단계와, 동결 건조한 후 분말화 시키는 제4단계로 이루어지는 것을 특징으로 하는 진피의 품질향상 및 무배당체 화합물의 함량이 증가되는 진피 분말 제조방법The first step of washing the citrus fruits, the second step of separating and shredding the shells, the weight of the chopped shells and water were mixed at a ratio of 1: 3, and the cellulase, beta-glucanase, Wherein the enzyme treatment concentration of the dermis is 1.1 to 1.8% based on the total volume of the mixture and the reaction time is from 15 to 20 hours; and a fourth step of lyophilizing the powder after lyophilization. Production of dermis powder with improved quality and increased content of non-dodecyl compound 제 1항의 제조방법으로 이루어지는 것을 특징으로 하는 진피 품질특성 특히 용출수율 증대 및 무배당체 화합물의 함량이 증가되는 진피 분말A process for producing a dermis powder according to claim 1, wherein the dermis comprises a dermis powder having a dermis quality characteristic, 상기 제2항의 진피 분말 49.10중량%, 유당 16.37중량%, 전분 16.37중량%, 포도당 16.37중량%, 만닛톨 1.63중량%, 비타민 C 0.08중량%, 사과산 0.08중량%를 혼합한 후, A mixture of 49.10% by weight of the dermis powder, 16.37% by weight of lactose, 16.37% by weight of starch, 16.37% by weight of glucose, 1.63% by weight of mannitol, 0.08% by weight of vitamin C and 0.08% 상기 혼합물의 중량대비 5~10% 물을 첨가하여 혼합한 후 18mesh 걸러낸 5 to 10% water is added to the mixture and mixed. After 18mesh filtering 후, 통과되어 나온 물질을 50℃에서 2시간 건조하여 구성되는 것을 특징으로 하는 진피의 품질향상 및 무배당체 화합물의 함량이 증가되는 진피 분말이 포함된 조성물 And then dried at 50 DEG C for 2 hours. The composition comprising the dermis powder, which is improved in the quality of the dermis and the content of the non-dodecyl compound, is increased
KR1020070041523A 2007-04-27 2007-04-27 Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder KR100900810B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070041523A KR100900810B1 (en) 2007-04-27 2007-04-27 Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070041523A KR100900810B1 (en) 2007-04-27 2007-04-27 Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder

Publications (2)

Publication Number Publication Date
KR20080096273A KR20080096273A (en) 2008-10-30
KR100900810B1 true KR100900810B1 (en) 2009-06-04

Family

ID=40155675

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070041523A KR100900810B1 (en) 2007-04-27 2007-04-27 Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder

Country Status (1)

Country Link
KR (1) KR100900810B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980002707A (en) * 1996-06-18 1998-03-30 이대원 Cooling blades of turbine
KR20040001551A (en) * 2002-06-28 2004-01-07 (주)미네모아 An enzyme extracting method of skin extract including hesperidin and the skin extract thereby, an extracting method of mineral extract from chenopodiaceae and the mineral extract thereby, an composition including the skin extract and the mineral extract, and an using method of the skin extract, the mineral extract or the composition for food addition
KR20060084335A (en) * 2005-01-19 2006-07-24 백흥관 Method for preparing enzyme using guava

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980002707A (en) * 1996-06-18 1998-03-30 이대원 Cooling blades of turbine
KR20040001551A (en) * 2002-06-28 2004-01-07 (주)미네모아 An enzyme extracting method of skin extract including hesperidin and the skin extract thereby, an extracting method of mineral extract from chenopodiaceae and the mineral extract thereby, an composition including the skin extract and the mineral extract, and an using method of the skin extract, the mineral extract or the composition for food addition
KR20060084335A (en) * 2005-01-19 2006-07-24 백흥관 Method for preparing enzyme using guava

Also Published As

Publication number Publication date
KR20080096273A (en) 2008-10-30

Similar Documents

Publication Publication Date Title
JP5354833B2 (en) α-Amylase activity inhibitor
KR101408814B1 (en) Korean medicinal tea and health functional food having strong antioxidant activity and high acceptabilitythe
KR102005790B1 (en) Method for producing functional Kochujang comprising medicinal plants
CN102648751A (en) Engineering rice with functions of alleviating hangover and protecting liver and preparation method of engineering rice
KR101017594B1 (en) Preparation of fermented onion containing increased quercetin content
KR100567846B1 (en) A method for preparing mulberry leaf tea
KR101971857B1 (en) Method for producing functional cabbage juice comprising medicinal herb
KR100900810B1 (en) Method for preparing of Korean citrus peel increased of aglycone flavnoid and mixture containing the powder
KR101465842B1 (en) Method for preparation of extracts of berries and colored potatos comprising anthocyanin-based pigments using Pectinex Ultra SP-L
KR101400103B1 (en) Manufacturing method for tea of Momordica charantia having improved palatability and antioxidant activity
KR101084939B1 (en) Composition comprising the extract of sea algae for preventing and treating hypertension
KR101636608B1 (en) Composition for antioxidation comprising the seed extract of cornus officinalis
KR102005795B1 (en) Method for producng functional tea using Cudrania tricuspidata
KR101832710B1 (en) Method for reducing hazardous ingredients in black ginseng concentrate by treating active carbon
KR101321769B1 (en) Manufacture method of rice juice by oriental medicine
KR101889733B1 (en) Lotus root grain syrup, and manufacturing method thereof
KR100935400B1 (en) Ligularia fischeri buckwheat cold noodle to add hot water extract of Angelica gigas Nakai or Astragalus membranaceus and process for preparing the said buckwheat cold noodle
KR20150085215A (en) Composition comprising black garlic and Gastrodia elata extract with antioxidant activity and method of making the same
KR101651100B1 (en) ISOLATED SINGLE COMPOUND FROM Mori Cortex Radicis ITS APPLICATION IN TREATING AND PREVENTING OBESITY
KR102504384B1 (en) Manufacturing method for salt of mulberry or mulberry leaf
CN109418991A (en) Tea seed cake tea Pu is used for the application method of food and health care product
KR102102872B1 (en) Method for manufacturing cheonggukjang having a soybean shape and cheonggukjang manufactured thereby
KR102504383B1 (en) Manufacturing method for salt of mulberry or mulberry leaf
KR102044607B1 (en) Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof
KR102256509B1 (en) Composition comprising extract of dendropanax mobifera having neuronal cell-protecting activity for preventing and treating brain diseases

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
N231 Notification of change of applicant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130313

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20140312

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20160518

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20170517

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20181031

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20190626

Year of fee payment: 11